Cardiff Oncology Inc (NASDAQ:CRDF)’s traded shares stood at 0.61 million during the last session, with the company’s beta value hitting 2.01. At the close of
In the last trading session, 2.16 million Cardiff Oncology Inc (NASDAQ:CRDF) shares changed hands as the company’s beta touched 1.96. With the company’s per share
In last trading session, Cardiff Oncology Inc (NASDAQ:CRDF) saw 0.82 million shares changing hands with its beta currently measuring 1.96. Company’s recent per share price
Cardiff Oncology Inc (NASDAQ:CRDF) has a beta value of 1.96 and has seen 1.42 million shares traded in the last trading session. The company, currently
During the recent session, Cardiff Oncology Inc (NASDAQ:CRDF)’s traded shares were 0.71 million, with the beta value of the company hitting 1.97. At the last
In the last trading session, 1.97 million Cardiff Oncology Inc (NASDAQ:CRDF) shares changed hands as the company’s beta touched 1.92. With the company’s per share
In the latest trading session, 0.91 million Cardiff Oncology Inc (NASDAQ:CRDF) shares changed hands as the company’s beta touched 1.92. With the company’s most recent
In recent trading session, Cardiff Oncology Inc (NASDAQ:CRDF) saw 1.18 million shares changing hands at last check today with its beta currently measuring 1.90. Company’s
Cardiff Oncology Inc (NASDAQ:CRDF) has a beta value of 1.70 and has seen 2.0 million shares traded in the last trading session. The company, currently
During the last session, Cardiff Oncology Inc (NASDAQ:CRDF)’s traded shares were 3.95 million, with the beta value of the company hitting 1.74. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
